Skip Nav Destination
OnlineFirst
September 27 2023
Peritumoral immune suppressive mechanisms impede intratumoral lymphocyte infiltration into CRC liver versus lung metastases
Jian Ye; Weihua Guo; Chongkai Wang; Colt A Egelston; Massimo D'Apuzzo; Geereesh Shankar; Marwan G Fakih; Peter P Lee
Cancer Research Communications (2023)
September 27 2023
DNA2 nuclease inhibition confers synthetic lethality in cancers with mutant p53 and synergizes with PARP inhibitors
Cancer Research Communications (2023)
September 21 2023
Chromatin accessibility landscape of human triple-negative breast cancer cell lines reveals variation by patient donor ancestry
Alexandra R Harris; Gatikrushna Panigrahi; Huaitian Liu; Vishal N Koparde; Maeve Bailey-Whyte; Tiffany H Dorsey; Clayton C. Yates; Stefan Ambs
Cancer Research Communications (2023)
September 21 2023
Piperacetazine directly binds to the PAX3::FOXO1 fusion protein and inhibits its transcriptional activity.
Kay Nakazawa; Taryn Shaw; Young K Song; Marilyn Kouassi-Brou; Anna Molotkova; Purushottam B Tiwari; Hsien-Chao Chou; Xinyu Wen; Jun S. Wei; Emre Deniz; Jeffrey Toretsky; Charles Keller; Frederic G. Barr; Javed Khan; Aykut Üren
Cancer Research Communications (2023)
September 20 2023
Metastatic competency and tumor spheroid formation are independent cell states governed by RB in lung adenocarcinoma
Cancer Research Communications (2023)
September 20 2023
The inherited KRAS-variant as a biomarker of Cetuximab Response in NSCLC
Joanne B Weidhaas; Chen Hu; Ritsuko Komaki; Gregory A Masters; George R Blumenschein; Joe Y. Chang; Bo Lu; Adam P. Dicker; Jeffrey A Bogart; Yolanda I Garces; Samir Narayan; Clifford G. Robinson; Vivek S Kavadi; Joel S Greenberger; Christopher D Koprowski; James W. Welsh; Elizabeth Gore; Robert M MacRae; Rebecca Paulus; Jeffrey Bradley
Cancer Research Communications (2023)
September 18 2023
Integrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms: An NCI Cancer Moonshot Precancer Atlas Pilot Project
Alexander Semaan; Vincent Bernard; Justin W Wong; Yuki Makino; Daniel B Swartzlander; Kimal I. Rajapakshe; Jaewon J Lee; Adam Officer; C. Max Schmidt; Howard H Wu; Courtney L Scaife; Kajsa Affolter; Daniela Nachmanson; Matthew A. Firpo; Michele Yip-Schneider; Andrew M. Lowy; Olivier Harismendy; Subrata Sen; Anirban Maitra; Yasminka A Jakubek; Paola A. Guerrero
Cancer Research Communications (2023)
September 13 2023
Combined targeting of NAD biosynthesis and the NAD-dependent transcription factor C-terminal Binding Protein as a promising novel therapy for pancreatic cancer
M. Michael Dcona; Kranthi Kumar Chougoni; Diana T. Dcona; Jacqueline L West; Sahib J. Singh; Keith C. Ellis; Steven R. Grossman
Cancer Research Communications (2023)
September 13 2023
Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer.
Anjali Yadav; Tanay Biswas; Ayush Praveen; Promit Ganguly; Ankita Bhattacharyya; Ayushi Verma; Dipak Datta; Bushra Ateeq
Cancer Research Communications (2023)
September 12 2023
Change in Neighborhood Socioeconomic Status and Adherence to the Cancer Prevention Lifestyle Guidelines in Hispanic/Latino Adults: Results from the HCHS/SOL Study
Margaret S Pichardo; Catherine Pichardo; Gregory A Talavera; Linda C Gallo; Charlene C Kuo; Sheila F Castañeda; Earle C Chambers; Martha Daviglus; Amber Pirzada; Krista M Perreira; Daniela Sotres-Alvarez; Tania Yadhira Peña Ortiz; Jesse J. Plascak
Cancer Research Communications (2023)
